Clinical Trial Update: HD11 for Intermediate Stages [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial named HD11 for intermediate-stage Hodgkin lymphoma has completed, sponsored by the University of Cologne. The snippet does not provide …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• HD11

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin´s Lymphoma | Phase 3 | Status: COMPLETED